INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 100 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 2.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $28,061,000 | -66.8% | 1,754,828 | -40.6% | 0.02% | -66.7% |
| Q4 2015 | $84,632,000 | -59.7% | 2,956,062 | -59.9% | 0.07% | -23.4% |
| Q3 2015 | $209,886,000 | +70.7% | 7,374,766 | +115.4% | 0.09% | -6.9% |
| Q2 2015 | $122,979,000 | +31.5% | 3,423,705 | +112.7% | 0.10% | +31.2% |
| Q1 2015 | $93,555,000 | +21.2% | 1,609,402 | -12.1% | 0.08% | +16.7% |
| Q4 2014 | $77,191,000 | +28.8% | 1,830,899 | +18.5% | 0.07% | +20.0% |
| Q3 2014 | $59,940,000 | +56.5% | 1,545,633 | +26.0% | 0.06% | +57.1% |
| Q2 2014 | $38,307,000 | +104.8% | 1,226,604 | +171.7% | 0.04% | +105.9% |
| Q1 2014 | $18,705,000 | +113.6% | 451,487 | +99.6% | 0.02% | +112.5% |
| Q4 2013 | $8,755,000 | – | 226,173 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 697,763 | $27,010,000 | 4.43% |
| Tamarack Capital Management, LLC | 235,000 | $9,097,000 | 2.15% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 196,117 | $7,591,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 132,862 | $6,093,000 | 0.36% |
| EMERALD ADVISERS, LLC | 118,242 | $4,577,000 | 0.25% |
| PDT Partners, LLC | 30,038 | $1,163,000 | 0.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 96,334 | $3,729,000 | 0.14% |
| Convergence Investment Partners, LLC | 17,450 | $675,000 | 0.11% |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 122,556 | $4,744,000 | 0.11% |
| Spark Investment Management LLC | 13,992 | $541,000 | 0.09% |